Results 271 to 280 of about 171,261 (332)

Efficacy of Vonoprazan for Refractory Reflux Esophagitis after Esophagectomy.

Dig Dis, 2021
Ochiai Y, Iizuka T, Hoshihara Y, Suzuki Y, Hayasaka J, Nomura K, Tanaka M, Odagiri H, Yamashita S, Matsui A, Kikuchi D, Ueno M, Udagawa H, Hoteya S.   +13 more
europepmc   +1 more source

A significantly reduced esophageal epidermal growth factor secretion in patients with reflux esophagitis: Its potential clinical significance

, 2003
Cezary Popławski, Tomasz Skoczylas, Z Namiot, Marek Marcinkiewicz, Tomasz Jaworski, M. F. O' Rourke, Meade C. Edmunds, George F. Goldin, Richard W. McCallum, Jerzy Sarosiek   +9 more
openalex   +1 more source

PPI therapy is equally effective in well‐defined non‐erosive reflux disease and in reflux esophagitis: a meta‐analysis

Neurogastroenterology and Motility, 2012
P. W. Weijenborg, F. Cremonini, A. Smout, A. Bredenoord   +3 more
semanticscholar   +1 more source

The significance of determination of epithelial neutrophil activating peptide-78(ENA-78) on reflux esophagitis

, 2003
Fumiaki Yano, Nobuo Omura, Kazuto Tsuboi, Yutaka Suzuki, Sadanobu ABE, Hideyuki Kashiwagi, Yasukazu Ohmoto   +6 more
openalex   +1 more source

Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease

, 2004
David A. Johnson, M. Brian Fennerty
openalex   +1 more source

Symptom association probability for acid and non-Acid reflux in patients with erosive esophagitis (EE) and non-Erosive reflux disease (NERD). [PDF]

, 2009
Parodi, A, Pohl, D, Sammito, G, Savarino, E, Savarino, V., Tutuian, R, Vigneri, Simone, Zentilin, P   +7 more
core  

Some of the next articles are maybe not open access.

Related searches:

Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis

Hepatology Research, 2022
Reflux esophagitis is associated with metabolic dysfunction. Recently, fatty liver has been redefined as metabolic dysfunction‐associated fatty liver disease (MAFLD).
S. Fukunaga, D. Nakano, Tsubasa Tsutsumi, T. Kawaguchi, M. Eslam, Shinobu Yoshinaga, Hirohiko Abe, R. Nouno, S. Joh, K. Mitsuyama, J. George, T. Torimura   +11 more
semanticscholar   +1 more source

Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease

American Journal of Gastroenterology, 2022
INTRODUCTION: The Lyon Consensus designates Los Angeles (LA) grade C/D esophagitis or acid exposure time (AET) >6% on impedance-pH monitoring (MII-pH) as conclusive for gastroesophageal reflux disease (GERD).
Pierfrancesco Visaggi, G. Del Corso, C. Gyawali, M. Ghisa, F. Baiano Svizzero, Delio Stefani Donati, A. Venturini, V. Savarino, R. Penagini, S. Zeki, M. Bellini, E. Savarino, N. de Bortoli   +12 more
semanticscholar   +1 more source

Esophageal Reflux and Esophagitis

JAMA: The Journal of the American Medical Association, 1971
To the Editor.— Symptoms resulting from esophageal reflux and esophagitis are encountered frequently in medical practice. Various pain patterns, anxiety, dysphagia, regurgitation, bleeding, nocturnal cough, and wheezing are some of the familiar hallmarks of esophagitis and reflux.
G. A. Diettert, W. A. Reynolds
openaire   +3 more sources

Reflux Esophagitis

Scandinavian Journal of Gastroenterology, 1990
The various therapeutic approaches for reflux esophagitis are to increase the competence of the antireflux barrier, to enhance esophageal clearance, to improve gastric emptying and pyloric sphincter competence, to coat damaged tissue, and, especially, to reduce the volume and pH of gastric contents.
G N, Tytgat, C Y, Nio, R H, Schotborgh
openaire   +2 more sources